This will be driven in particular by the public healthcare sector’s growing interest in existing advanced wound care technology.
New analysis from global growth consulting company Frost & Sullivan (medicaldevices.frost.com), South African Advanced Wound Care Market, finds that the market earned revenues of $32.7 million in 2006 and estimates this to increase 2.5 times by 2012.
"Advanced wound care products encourage faster wound healing and reduced nursing time in hospitals, leading to earlier hospital discharge and a higher utilisation of hospital beds," notes Frost & Sullivan Research Analyst Lizelle Wentzel. "This represents an important advantage to the healthcare industry and companies should focus on this aspect as part of their marketing strategies."
The market is also expanding due to the increased adoption of available technology by the public sector, the launch of new technology and dressings and growing awareness. The significant long-term cost advantages offered by advanced wound care management are also reinforcing market growth.
Advanced wound care, as a segment of traditional wound care, is growing rapidly and will eventually dominate the traditional wound care market in the long term. The launch of new and improved or combination dressings will contribute significantly to market growth.
The current trend in the advanced wound care market is to combine existing dressings, such as the integration of collagen, hyaluronic acid and silver into moist wound healing products. Convatec's Versiva, for example, is a combination of three technologies: foam-film, hydrofibre and hydrocolloid.
The need for greater efficiency in the healthcare systems will require suppliers to demonstrate the cost effectiveness of their products. Such an evidence-based healthcare philosophy will mean that relationships with key medical aid schemes will be essential to sustaining growth.
"South Africa’s public health sector still has a ‘price-per-piece’ rather than a ‘total cost’ approach," explains Wentzel. "While manufacturers are moving in the direction of providing evidence to support the latter, the increased need to provide such proof is likely to retard the uptake of new concepts such as tissue engineering and biomaterial dressings for chronic wounds."
Understanding end users and the level of market readiness for a new product will pose key challenges. Until end users comprehend both concept and cost benefits, a takeoff in demand is unlikely.
"For every product launch strategy, a detailed market potential analysis must be undertaken," advises Wentzel. "Simultaneously, enhanced penetration and expansion can be achieved through demonstrating long-term cost benefits and employing awareness strategies."
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the investment analysis and growth opportunities in the South African Advanced Wound Care Market, then send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com , with your full name, company name, title, telephone number, fax number, and email address. Upon receipt of the above information, an overview will be sent to you by email.
Strategic Analysis of the South African Advanced Wound Care Market is part of the Medical Devices Growth Partnership Services Programme, which also includes research in the following markets: pharmaceuticals, medical devices and medical imaging. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
About Frost & Sullivan
Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.